Bausch Health Companies | VRX - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Amgen USD 19.52B 1.37B 2026-03
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Bausch Health Companies USD 593M 7M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Canopy Growth CAD 34.82M 14.85M 2026-03
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Danaher USD 2.07B 282M 2026-06
Drreddys Laboratories INR 22.36B 21.91B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novo Nordisk DKK 14.8B 4.96B 2026-03
Pacira USD 14.01M 1.14M 2026-03
Perrigo USD 434.8M 39.7M 2026-03
Phibro Animal Health USD 129.64M 3.65M 2026-03
Prestige Brands USD 22.79M 20.15M 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Zoetis USD 507M 20M 2026-03